Neurotoxicity of methamphetamine: Main effects and mechanisms.
Jayanthi S, Daiwile AP, Cadet JL.
Exp Neurol. 2021 Oct;344:113795. doi: 10.1016/j.expneurol.2021.113795. Epub 2021 Jun 26.
Cefepime-induced neurotoxicity: a systematic review.
Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL.
Crit Care. 2017 Nov 14;21(1):276. doi: 10.1186/s13054-017-1856-1.
MRI Spectrum of Toxic Encephalopathy-An Institutional Experience.
Biswas S, Pendharkar HS, Murumkar VS.
Neurol India. 2022 Jul-Aug;70(4):1525-1533. doi: 10.4103/0028-3886.355127.
Reactions Related to CAR-T Cell Therapy.
Miao L, Zhang Z, Ren Z, Li Y.
Front Immunol. 2021 Apr 28;12:663201. doi: 10.3389/fimmu.2021.663201. eCollection 2021.
Neurologic complications of immune checkpoint inhibitors.
Haugh AM, Probasco JC, Johnson DB.
Expert Opin Drug Saf. 2020 Apr;19(4):479-488. doi: 10.1080/14740338.2020.1738382. Epub 2020 Mar 11.
Excitotoxicity and stroke: identifying novel targets for neuroprotection.
Lai TW, Zhang S, Wang YT.
Prog Neurobiol. 2014 Apr;115:157-88. doi: 10.1016/j.pneurobio.2013.11.006. Epub 2013 Dec 17.
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity.
Santomasso BD, Gust J, Perna F.
Blood. 2023 May 18;141(20):2443-2451. doi: 10.1182/blood.2022017604.
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.
Hay KA, Hanafi LA, Li D, Gust J, Liles WC, Wurfel MM, López JA, Chen J, Chung D, Harju-Baker S, Cherian S, Chen X, Riddell SR, Maloney DG, Turtle CJ.
Blood. 2017 Nov 23;130(21):2295-2306. doi: 10.1182/blood-2017-06-793141. Epub 2017 Sep 18.
Toxic Neuropathies.
Karam C, Dyck PJ.
Semin Neurol. 2015 Aug;35(4):448-57. doi: 10.1055/s-0035-1558977. Epub 2015 Oct 6.
Neurotoxicity in a child after ingestion of star anise.
Mansouri A, Huusom AJ, Hjortshøj C.
Ugeskr Laeger. 2023 Jan 30;185(5):V06220370.
